Arrowhead Pharmaceuticals, Inc. (LON: 0HI3)
London
· Delayed Price · Currency is GBP · Price in USD 19.71
+0.01 (0.05%)
Jan 22, 2025, 6:52 PM BST
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 1.99 billion as of January 23, 2025. Its market cap has decreased by -42.17% in one year.
Market Cap
1.99B
Enterprise Value
2.14B
Revenue
2.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.71
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 1.99B, an increase of 10,997.50%. That is a compound annual growth rate of 25.08%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |